Stroke treatment using intravenous and intra-arterial tissue plasminogen activator

Current Treatment Options in Cardiovascular Medicine

Volumn 14, Issue 3, 2012, Pages 273-283

  Miller, Joseph ^a   Hartwell, Christopher ^a   Lewandowski, Christopher ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Intra arterial thrombolysis; Mechanical thrombectomy; Stroke; T PA; Thrombolytics

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; DESMOTEPLASE; DIPYRIDAMOLE; FIBRINOLYTIC AGENT; PLACEBO; TENECTEPLASE; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BLEEDING; BLOOD CLOT LYSIS; BLOOD PRESSURE MONITORING; BRAIN ISCHEMIA; CLOT EXTRACTION DEVICE; COST EFFECTIVENESS ANALYSIS; DEVICES; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG COST; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; HUMAN; OUTCOME ASSESSMENT; PROTHROMBIN TIME; QUALITY OF LIFE; RECANALIZATION; THROMBOCYTE COUNT;

EID: 84865687119     PISSN: 10928464     EISSN: 15343189     Source Type: Journal    
DOI: 10.1007/s11936-012-0176-7     Document Type: Article

References (41)

1. Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119(3):480-6.
2. Kelly-Hayes M, Beiser A, Kase CS, et al. The influence of gender and age on disability following ischemic stroke: the Framingham study. J Stroke Cerebrovasc Dis. 2003;12(3): 119-26. (Pubitemid 36870484)
3. Brown DL, Boden-Albala B, Langa KM, et al. Projected costs of ischemic stroke in the United States. Neurology. 2006;67(8):1390-5. (Pubitemid 44632062)
4. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333(24):1581-7.
5. Kwiatkowski TG, Libman RB, Frankel M, et al. Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. N Engl J Med. 1999;340(23):1781-7.
6. Saver JL. Hemorrhage after thrombolytic therapy for stroke: the clinically relevant number needed to harm. Stroke. 2007;38:2279-83. (Pubitemid 47457569)
7. Zivin JA. Acute stroke therapy with tissue plasminogen activator (tPA) since it was approved by the U.S. Food and Drug Administration (FDA). Ann Neurol. 2009;66(1):6-10.
8. Hacke W, Donnan G, Fieschi C, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004;363(9411):768-74.
9. Wahlgren N, Ahmed N, Davalos A, et al. Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet. 2008;372(9646):1303-9.
10. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 h after acute ischemic stroke. N Engl J Med. 2008;359(13):1317-29.
11. Ahmed N, Wahlgren N, Grond M, et al. Implementation and outcome of thrombolysis with alteplase 3-4.5 h after an acute stroke: an updated analysis from SITS-ISTR. Lancet Neurol. 2010;9(9):866-74.
12. Chernyshev OY, Martin-Schild S, Albright KC, et al. Safety of tPA in stroke mimics and neuroimagingnegative cerebral ischemia. Neurology. 2010;74 (17):1340-5.
13. Tsivgoulis G, Alexandrov AV, Chang J, et al. Safety and outcomes of intravenous thrombolysis in stroke mimics: a 6-year, single-care center study and a pooled analysis of reported series. Stroke. 2011;42 (6):1771-4.
14. Lees KR, Bluhmki E, von Kummer R, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet. 2010;375(9727):1695-703.
15. Adams HP, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/ American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007;38 (5):1655-711. (Pubitemid 46691097)
16. Wahlgren N, Ahmed N, Dávalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke- Monitoring Study (SITS-MOST): an observational study. Lancet. 2007;369(9558):275-82. (Pubitemid 46138121)
17. Fagan SC, Morgenstern LB, Petitta A, et al. Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group. Neurology. 1998;50(4):883-90. (Pubitemid 28212810)
18. Johnston SC. The economic case for new stroke thrombolytics. Stroke. 2010;41(10 Suppl):S59-62.
19. Lewandowski CA, Frankel M, Tomsick TA, et al. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke. 1999;30(12):2598-605.
20. Moustafa RR, Baron JC. Clinical review: imaging in ischaemic stroke-implications for acute management. Critical Care. 2007;11(5):227.
21. Blanc R, Pistocchi S, Babic D et al. Intravenous flatdetector CT angiography in acute ischemic stroke management. Neuroradiology. 2011.
22. Investigators IIT. The Interventional Management of Stroke (IMS) II study. Stroke. 2007;38(7):2127-35.
23. Investigators IMSS. Combined intravenous and intraarterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke. 2004;35(4):904-11.
24. Lee M, Hong KS, Saver JL. Efficacy of intra-arterial fibrinolysis for acute ischemic stroke: meta-analysis of randomized controlled trials. Stroke. 2010;41 (5):932-7.
25. Lindsberg PJ, Mattle HP. Therapy of basilar artery occlusion: a systematic analysis comparing intra-arterial and intravenous thrombolysis. Stroke. 2006;37 (3):922-8. (Pubitemid 43731936)
26. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999;282 (21):2003-11.
27. Smith WS, Sung G, Starkman S, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke. 2005;36 (7):1432-8. (Pubitemid 40967507)
28. Smith WS, Sung G, Saver J, et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke. 2008;39(4):1205-12. (Pubitemid 351440692)
29. Patil CG, Long EF, Lansberg MG. Cost-effectiveness analysis of mechanical thrombectomy in acute ischemic stroke. J Neurosurg. 2009;110(3):508-13.
30. Nguyen-Huynh MN, Johnston SC. Is mechanical clot removal or disruption a cost-effective treatment for acute stroke? AJNR. 2011;32(2):244-9.
31. Penumbra Pivotal Stroke Trial I. The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke. 2009;40(8):2761-8.
32. Davydov L, Cheng JW. Tenecteplase: a review. Clin Ther. 2001;23(7):982-97. (Pubitemid 32709622)
33. Parsons MW, Miteff F, Bateman GA, et al. Acute ischemic stroke: imaging-guided tenecteplase treatment in an extended time window. Neurology. 2009;72(10):915-21.
34. Medcalf RL. Desmoteplase: discovery, insights and opportunities for ischaemic stroke. Br J Pharmacol. 2012;165(1):75-89.
35. Michel P, Ntaios G, Reichhart M, et al. Perfusion- CT guided intravenous thrombolysis in patients with unknown-onset stroke: a randomized, double- blind, placebo-controlled, pilot feasibility trial. Neuroradiology. 2011.
36. Wintermark M, Meuli R, Browaeys P, et al. Comparison of CT perfusion and angiography and MRI in selecting stroke patients for acute treatment. Neurology. 2007;68(9):694-7. (Pubitemid 46667819)
37. Yoo AJ, Verduzco LA, Schaefer PW, et al. MRI-based selection for intra-arterial stroke therapy: value of pretreatment diffusion-weighted imaging lesion volume in selecting patients with acute stroke who will benefit from early recanalization. Stroke. 2009;40(6):2046-54.
38. Alexandrov AV, Molina CA, Grotta JC, et al. Ultrasound- enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med. 2004;351 (21):2170-8. (Pubitemid 39507629)
39. Tsivgoulis G, Eggers J, Ribo M, et al. Safety and efficacy of ultrasound-enhanced thrombolysis: a comprehensive review and meta-analysis of randomized and nonrandomized studies. Stroke. 2010;41 (2):280-7.
40. Khatri P, Hill MD, Palesch YY, et al. Methodology of the Interventional Management of Stroke III Trial. Int J Stroke. 2008;3(2):130-7. (Pubitemid 351566847)
41. Ansari S, McConnell DJ, Azari H, et al. Impact of intracranial self-expanding stents in the treatment of acute ischemic stroke: efficacy and limitations. J Neurointerv Surg. 2011 Feb 10 [Epub ahead of print].